Literature DB >> 3377944

Pharmacokinetics of fentanyl in the elderly.

M A Singleton1, J I Rosen, D M Fisher.   

Abstract

The pharmacokinetics of fentanyl were determined in seven elderly (71-82 yr) and seven younger adults (18-41 yr) anaesthetized with thiopentone, nitrous oxide in oxygen and morphine. Fentanyl was administered as a 2-min i.v. infusion at doses of 15 micrograms kg-1 for elderly patients and 20 micrograms kg-1 for the younger patients. Plasma samples were obtained for 4 h and fentanyl concentrations determined by radioimmunoassay. Fentanyl concentration, per microgram kg-1 administered, was higher in elderly than in young patients at 2 min (7.73 +/- 3.14 v. 4.54 +/- 1.83 ng ml-1 (mean +/- SD), respectively) and at 4 min after the start of infusion (3.26 +/- 1.44 v. 1.78 +/- 0.72 ng ml-1, respectively). Concentrations were similar at all other sampling times. Pharmacokinetic variables were determined by non-compartmental techniques. Total plasma clearance was similar for the two age groups. Volume of distribution at steady-state (VDss) was smaller in elderly patients (1.36 +/- 0.44 v. 2.27 +/- 0.82 litre kg-1). Despite age-related changes in VDss, plasma fentanyl concentrations for the two groups were similar throughout the 4-h sampling period except immediately following administration. These results suggest that, if there are age-related differences in response to fentanyl, the likely pharmacokinetic explanation is the higher concentration of fentanyl in the elderly immediately following its administration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377944     DOI: 10.1093/bja/60.6.619

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment.

Authors:  Andrew J McLachlan; Sally Bath; Vasi Naganathan; Sarah N Hilmer; David G Le Couteur; Stephen J Gibson; Fiona M Blyth
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 3.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 4.  Anaesthesia in the elderly. Special considerations.

Authors:  A G Jones; J M Hunter
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

5.  Pharmacokinetics of sufentanil in the elderly surgical patient.

Authors:  R S Matteo; A E Schwartz; E Ornstein; W L Young; W J Chang
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

Review 6.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 7.  A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Authors:  Evelien J M Kuip; Maarten L Zandvliet; Stijn L W Koolen; Ron H J Mathijssen; Carin C D van der Rijt
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

Review 8.  Free drug metabolic clearance in elderly people.

Authors:  Jennifer M Butler; Evan J Begg
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Population Pharmacokinetics of Fentanyl in the Critically Ill.

Authors:  Leena Choi; Benjamin A Ferrell; Eduard E Vasilevskis; Pratik P Pandharipande; Rebecca Heltsley; E Wesley Ely; C Michael Stein; Timothy D Girard
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

Review 10.  Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance.

Authors:  Jing Zhao; Xin Xin; Guo-xi Xie; Pamela Pierce Palmer; Yu-guang Huang
Journal:  Mol Pain       Date:  2012-05-21       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.